Prevalence of Mild Cognitive Impairment and Associated Factors in Type 2 Diabetes Mellitus at King Chulalongkorn Memorial Hospital, Thai Red Cross Society
Article Sidebar
Main Article Content
Abstract
Background: This study aimed to identify factors associated with mild cognitive impairment (MCI) in Thai adults with type 2 diabetes mellitus (T2DM).
Methods: A total of 262 adults participated in this study. A diagnosis of MCI was based on the criteria of Petersen. Cognitive function was assessed with the Montreal Cognitive Assessment-Thai version (MoCA-T).
Results: The prevalence of MCI was 67.4%. In a logistic regression analysis, age (p = 0.001, OR = 1.062, 95% CI = 1.024 – 1.103), Metformin (p = 0.048, OR = 2.440, 95%CI = 1.009-5.903), education level ((12-15 years vs 0-5 years) (p = 0.006, OR = 0.212, 95% CI = 0.070-0.639)) and education level ((≥ 16 years vs 0-5 years) (p = 0.000, OR = 0.043, 95% CI = 0.015 -0.122)) were associated with MCI among T2DM patients.
Conclusion: More concentrated efforts focused on early detection and appropriate management of MCI may be required in Thai adults with type 2 diabetes mellitus.
Article Details
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
2. CentersforDiseaseControlandPrevention. Incidence of Diagnosed Diabetes 2018 [Available from: https://www.cdc.gov/diabetes/data/statistics-report/incidence-diabetes.html.
3. Yukiko Mori AF, Hidetomo Murakami, Kyoko Kohashi, Tsutomu Hirano and Mitsuru Kawamura. Increased detection of mild cognitive impairment with type 2 diabetes mellitus using the Japanese version of the Montreal Cognitive Assessment: Apilot study. Neurology and Clinical Neuroscience. 2015(3).
4. Munshi MN. Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know. Diabetes Care. 2017;40.
5. Wei Li LS, Guanjun Li, Shifu Xiao. Prevalence, Influence Factors and Cognitive Characteristics of Mild Cognitive Impairment in Type 2 Diabetes Mellitus. Front Aging Neurosci. 2019;2019.
6. WG C. Sampling techniques. 3rd ed. New York: John Wiley & Sons; 1977.
7. F Portet PJO, P J Visser, G B Frisoni, F Nobili, Ph Scheltens, B Vellas, J Touchon, the MCI Working Group of the European Consortium on Alzheimer's Disease (EADC). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry. 2006;2016(77):714-8.
8. Tangwongchai S CT, Phanasathit M, Akkayagorn L, Hemrungrojn S, Phanthumchinda K, Nasreddine ZS. The Validity of Thai version of The Montreal Cognitive Asseement (MoCA-T). Dement Neuropsychol. 2009.
9. Kannayiram Alagiakrishnan NZ, Laurie Mereu, Peter Senior and Ambikaipakan Senthilselvan. Montreal Cognitive Assessment Is Superior to Standardized Mini-Mental Status Exam in Detecting Mild Cognitive Impairment in the Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus. BioMed Research International. 2013;2013.
10. หล่อตระกูล ม, editor. บทที่ 31 เครื่องมือประเมินปัญหาสุขภาพจิตและจิตเวช2544.
11. ธนา นิลชัยโกวิทย์ มห, อุมาภรณ์ ไพศาลสุทธิเดช. การพัฒนาแบบสอบถาม Hospital Anxiety and Depression Scale ฉบับภาษาไทยในผู้ป่วยโรคมะเร็ง. วารสารสมาคมจิตแพทย์แห่งประเทศไทย. 2539;41(1):18-30.
12. ศรนรินทร์ กาญจนะโนพินิจ สเ, ฐิตวี แก้วพรสวรรค์. การศึกษาคุณสมบัติการวัดของแบบคัดกรอง Cognistat ฉบับภาษาไทย. วารสารสมาคมจิตแพทย์แห่งประเทศไทย. 2014.
13. Yun Jeong Lee HMK, Na Kyung Kim,Ju Yeon Yang,Jung Hyun Noh,Kyung Soo Ko,Byoung Doo Rhee. Factors Associated for Mild Cognitive Impairment in Older Korean Adults with Type 2 Diabetes Mellitus. Diabetes Metab J. 2014.
14. Coredath Venugopal Lalithambika CSA, Lakshmi Ammal Saraswathy, Renjitha Bhaskaran. Cognitive Impairment and its Association with Glycemic Control in Type 2 Diabetes Mellitus Patients. Indian Journal of Endocrinology and Metabolism. 2019.
15. Louren Blanquisco JEA, Bonifacio Buno II, Laura Trajano-Acampado, Alvin Cenina, Darby Santiago. Factors Associated with Mild Cognitive Impairment among Elderly Filipinos with Type 2 Diabetes Mellitus. Journal of the ASEAN Federation of Endocrine Societies. 2017;2017.
16. Wennberg AMV, Hagen CE, Edwards K, Roberts RO, Machulda MM, Knopman DS, et al. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging. Int J Geriatr Psychiatry. 2018;33(8):1114-20.
17. Chaudhari K. Metformin and cognition from the perspectives of sex, age, and disease. GeroScience. 2020;42:97.
18. Koekkoek PS. Cognitive function in patients with diabetes mellitus : guidance for daily care. Lancet Neural. 2015;14.
19. Hopkins R. Management of Adults With Diabetes and Cognitive Problems. the American Diabetes Association. 2016.
